Yaz, Yasmin and their generic versions, Ocella and Gianvi, are birth control pills that are prescribed for daily use. According to the Food and Drug Administration (FDA), these oral contraceptives have a higher risk of severe side effects than other birth control options.
In April 2012 the FDA updated the safety information for Yaz, Yasmin, Ocella, and Gianvi and required boxed warnings for their life-threatening effects including:
- Deep vein thrombosis
- Pulmonary embolism
Steven Skikos is the State-Federal Liaison Counsel to the consolidated California litigation in the MDL. Steven is also Plaintiffs’ Co-Liaison Counsel and serves on the Plaintiffs’ Executive Committee in the California Coordinated Proceeding.
Jane Joseph is a member of the Science Committee, and Mark Crawford is a member of the Discovery Committee in the MDL.